Triplex-forming oligonucleotides as modulators of gene expression

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 1, 2003, Pages 22-31

  Guntaka, Ramareddy V ^a   Varma, Balwantkumar R ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antigene; G quartet; Stability; Transcription; Triplex formation

Indexed keywords

CIS ACTING ELEMENT; MUTAGENIC AGENT; OLIGONUCLEOTIDE; PHOSPHATE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRANSCRIPTION FACTOR; DNA;

BINDING AFFINITY; CHROMOSOME SEGREGATION; DNA STRUCTURE; DNA SYNTHESIS; DOWN REGULATION; EUKARYOTE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC DISORDER; GENETIC TRANSCRIPTION; GENOME; HUMAN; NONHUMAN; PROKARYOTE; PROTEIN ANALYSIS; PROTEIN BINDING; REVIEW; TRIPLE HELIX; ANIMAL; CHEMISTRY; CONFORMATION; DRUG EFFECT; EUKARYOTIC CELL; GENE EXPRESSION REGULATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROKARYOTIC CELL;

ANIMALS; BASE SEQUENCE; DNA; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION; GENOME; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENS; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES; PROKARYOTIC CELLS;

EID: 0037211935     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00165-6     Document Type: Review

References (97)

1. Vasquez K.M., Wilson J.H. Triplex-directed modification of genes and gene activity. Trends Biochem. Sci. 23:1998;4-9.
2. Praseuth D., Guieysse A.L., Helene C. Triple helix formation and the antigene strategy for sequence-specific control of gene expression. Biochim. Biophys. Acta. 1489:1999;181-206.
3. Francois J.C., Lacoste J., Lacroix L., Mergny J.L. Design of antisense and triplex-forming oligonucleotides. Methods Enzymol. 313:2000;74-95.
4. Smith L., Andersen K.B., Hovgaard L., Jaroszewski J.W. Rational selection of antisense oligonucleotide sequences. Eur. J. Pharm. Sci. 11:2000;191-198.
5. Giovannangeli C., Helene C. Triplex-forming molecules for modulation of DNA information processing. Curr. Opin. Mol. Ther. 2:2000;288-296.
6. Kochetkova M., Shannon M.F. Triplex-forming oligonucleotides and their use in the analysis of gene transcription. Methods Mol. Biol. 130:2000;189-201.
7. Winters T.A. Gene targeted agents: new opportunities for rational drug development. Curr. Opin. Mol. Ther. 6:2000;670-681.
8. Casey B.P., Glazer P.M. Gene targeting via triple helix formation. Prog. Nucleic Acid Res. Mol. Biol. 67:2001;163-192.
9. Knauert M.P., Glazer P.M. Triplex-forming oligonucleotides: sequence-specific tools for gene targeting. Hum. Mol. Genet. 10:2001;2243-2251.
10. Frank-Kamenetskii M.D., Mirkin S.M. Triplex DNA structures. Ann. Rev. Biochem. 64:1995;65-95.
11. Agrawal S. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides. Biochim. Biophys. Acta. 1489:1999;53-68.
12. Williamson J.R., Raghuraman M.K., Cech T.R. Monovalent cation-induced structure of telomeric DNA: the G-quartet model. Cell. 59:1989;871-880.
13. Cheng A.J., van Dyke M.W. Oligodeoxyribonucleotide length and sequence effects on intra- and intermolecular G-quartet formation. Gene. 197:1997;253-260.
14. Laughlan G., Murchie A.I., Norman D.G., Moore M.H., Moody P.C., Lilley D.M., Luisi B. The high-resolution crystal structure of a parallel-stranded guanine tetraplex. Science. 265:1994;520-524.
15. Phillips K., Dauter Z., Murchie A.I., Lilley D.M., Luisi B. The crystal structure of a parallel-stranded guanine tetraplex at 0.95 Å resolution. J. Mol. Biol. 273:1997;171-182.
16. 2+ ions at subatomic resolution (0.61 Å). Proc. Natl. Acad. Sci. U.S.A. 98:2001;13660-13670.
17. 2 by the phosphotriester approach and its formation of G-quartet structure. Nucleic Acids Res. 30:2002;3005-3014.
18. Gee J.E., Revankar G.R., Rao T.S., Hogan M.E. Triplex formation at the rat neu gene utilizing imidazole and 2′-deoxy-6-thioguanosine base substitutions. Biochemistry. 34:1995;2042-2048.
19. Vasquez K.M., Wensel T.G., Hogan M.E., Wilson J.H. High affinity triple helix formation by synthetic oligonucleotides at a site within a selectable mammalian gene. Biochemistry. 34:1995;7243-7251.
20. Aubert Y., Perrouault L., Helene C., Giovannangeli C., Asseline U. Synthesis and properties of triple helix-forming oligodeoxyribonucleotides containing 7-chloro-7-deaza-2′-deoxyguanosine. Bioorg. Med. Chem. 9:2001;1617-1624.
21. Grimm G.N., Boutorine A.S., Lincoln P., Helene C. Design and simple routes of synthesis of oligonucleotide conjugates for studies of DNA triple helix formation. Nucleosides Nucleotides Nucleic Acids. 20:2001;909-914.
22. Ferdous A., Akaike T., Maruyama A. Mechanism of intermolecular purine-purine-pyrimidine triple helix stabilization by comb-type polylysine graft copolymer at physiologic potassium concentration. Bioconjug. Chem. 11:2000;520-526.
23. Obika S., Uneda T., Sugimoto T., Nanbu D., Minami T., Doi T., Imanishi T. 2′-O,4′-C-Methylene bridged nucleic acid (2′,4′-BNA): synthesis and triplex-forming properties. Bioorg. Med. Chem. 9:2001;1001-1011.
24. Cassidy R.A., Kondo N.S., Miller P.S. Triplex formation by psoralen-conjugated chimeric oligonucleoside methylphosphonates. Biochemistry. 39:2000;8683-8691.
25. Lacroix L., Arimondo P.B., Takasugi M., Helene C., Mergny J.L. Pyrimidine morpholino oligonucleotides form a stable triple helix in the absence of magnesium ions. Biochem. Biophys. Res. Commun. 270:2000;363-369.
26. Basye J., Trent J.O., Gao D., Ebbinghaus S.W. Triplex formation by morpholino oligodeoxyribonucleotides in the HER2/neu promoter requires the pyrimidine motif. Nucleic Acids Res. 29:2001;4873-4880.
27. Mills M., Arimondo P.B., Lacroix L., Garestier T., Klump H., Mergny J.L. Chemical modification of the third strand: differential effects on purine and pyrimidine triple helix formation. Biochemistry. 41:2002;357-366.
28. Torigoe H., Obika S., Imanishi T. Promotion of triplex formation by 2′-O,4′-C-methylene bridged nucleic acid (2′,4′-BNA) modification: thermodynamic and kinetic studies. Nucleosides Nucleotides Nucleic Acids. 20:2001;1235-1238.
29. Parsch U., Engels J.W. pH-independent triple helix formation with 6-oxocytidine as cytidine analogue. Chemistry. 6:2000;2409-2424.
30. Sorensen M.D., Meldgaard M., Raunkjaer M., Rajwanshi V.K., Wengel J. Branched oligonucleotides containing bicyclic nucleotides as branching points and DNA or LNA as triplex-forming branch. Bioorg. Med. Chem. Lett. 10:2000;1853-1856.
31. Hoyne P.R., Edwards L.M., Viari A., Maher L.J. III Searching genomes for sequences with the potential to form intrastrand triple helices. J. Mol. Biol. 302:2000;797-809.
32. Krasilniko A.S., Panyutin I.G., Samadashwily G.M., Cox R., Lazurkin Y.S., Mirkin S.M. Mechanisms of triplex-caused polymerization arrest. Nucleic Acids Res. 25:1997;1339-1346.
33. Diviacco S., Rapozzi V., Xodo L., Helene C., Quadrifoglio F., Giovannangeli C. Site-directed inhibition of DNA replication by triple helix formation. FASEB J. 15:2001;2660-2668.
34. Rao J.E., Miller P.S., Craig N.L. Recognition of triple-helical DNA structures by transposon Tn7. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3936-3941.
35. Jaworski A., Blaho J.A., Larson J.E., Shimuzu M., Wells R.D. Tetracycline promoter mutations decrease non-B DNA structural transitions, negative linking differences and deletions in recombinant plasmids in E. coli. J. Mol. Biol. 207:1989;513-526.
36. Watnick T.J., Piontem K.B., Cordal T.M., Weber H., Gandolph M.A., Qian F., Lens X.M., Newmann H.P., Germino G.G. An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection. Hum. Mol. Genet. 6:1997;1473-1481.
37. Blaszak R.T., Potaman V., Sinden R.R., Bissler J.J. DNA structural transitions within the PKD1 gene. Nucleic Acids Res. 27:1999;2610-2617.
38. R.D. Wells, S.T. Warren, Genetic Instabilities and Hereditary Neurological Diseases, Academic Press, San Diego, 1998.
39. *TTC repeats inhibit the formation of triplex and sticky DNA structures, alleviate transcription inhibition, and reduce genetic instabilities. J. Biol. Chem. 276:2001a;27178-27187.
40. *TTC repeats in intron 1 of the frataxin gene, inhibits transcription. J. Biol. Chem. 276:2001;27171-27177.
41. Jimenez-Garcia E., Vaquero A., Espinas M.L., Soliva R., Orozco M., Bernues J., Azorin F. The GAGA factor of Drosophila binds triple-stranded DNA. J. Biol. Chem. 273:1998;24640-24648.
42. Nelson L.D., Musso M., van Dyke M.W. The yeast STM1 gene encodes a purine motif triple-helical DNA-binding protein. J. Biol. Chem. 275:2000;5573-5581.
43. Musso M., Bianchi-Scarra G., van Dyke M.W. The yeast CDP1 gene encodes a triple-helical DNA-binding protein. Nucleic Acids Res. 28:2000;4090-4096.
44. Swamynathan S.K., Nambiar A., Guntaka R.V. Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes. FASEB J. 12:1998;515-522.
45. Vasquez K.M., Wilson J.H. Triplex-directed modification of genes and gene activity. Trends Biochem. Sci. 23:1998;4-9.
46. Cimino G.D., Gamper H.B., Isaacs S.T., Hearst J.E. Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry. Ann. Rev. Biochem. 54:1985;1151-1193.
47. Faruqi A.F., Datta H.J., Carroll D., Seidman M.M., Glazer P.M. Triple helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway. Mol. Cell. Biol. 20:2000;990-1000.
48. Barre F.X., Ait-Si-Ali S., Giovannangeli C., Luis R., Robin P., Pritchard L.L., Helene C., Harel-Bellan A. Unambiguous demonstration of triple helix-directed gene modification. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3084-3088.
49. Guieysse A.L., Praseuth D., Giovannangel C., Asseline U., Helene C. Psoralen adducts induced by triplex-forming oligonucleotides are refractory to repair in HeLa cells. J. Mol. Biol. 296:2000;373-383.
50. Luo Z., Macris M.A., Faruqi A.F., Glazer P.M. High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9003-9008.
51. Datta H.J., Chan P.P., Vasquez K.M., Gupta R.C., Glazer P.M. Triplex-induced recombination in human cell-free extracts: dependence on XPA and HsRad51. J. Biol. Chem. 276:2001;18018-18023.
52. Wang G., Chen Z., Zhang S., Wilson G.L., Jing K. Detection and determination of oligonucleotide triplex formation-mediated transcription-coupled DNA repair in HeLa nuclear extracts. Nucleic Acids Res. 29:2001;1801-1807.
53. Puri N., Majumdar A., Cuenoud B., Natt F., Martin P., Boyd A., Miller P.S., Seidman M.M. Targeted gene knockout by 2′-O-aminoethyl-modified triplex-forming oligonucleotides. J. Biol. Chem. 276:2001;28991-28998.
54. Vasquez K.M., Marburger K., Intody Z., Wilson J.H. Manipulating the mammalian genome by homologous recombination. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8403-8410.
55. Vasquez K.M., Narayanan L., Glazer P.M. Specific mutations induced by triplex-forming oligonucleotides in mice. Science. 290:2000;530-533.
56. Xu X.S., Glazer P.M., Wang G. Activation of human gamma-globin gene expression via triplex-forming oligonucleotide (TFO)-directed mutations in the gamma-globin gene 5′ flanking region. Gene. 242:2000;219-228.
57. Chan P.P., Lin M., Faruqi A.F., Powell J., Seidman M.M., Glazer P.M. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. J. Biol. Chem. 274:1999;11541-11548.
58. Culver K.W., Hsieh W.T., Huyen Y., Chen V., Liu J., Khripine Y., Khorlin A. Correction of chromosomal point mutations in human cells with bifunctional oligonucleotides. Nat. Biotechnol. 17:1999;989-993.
59. Vasquez K.M., Dagle J.M., Weeks D.L., Glazer P.M. Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides. J. Biol. Chem. 276:2001;8536-8541.
60. 125I -labeled triplex-forming oligonucleotides is highly mutagenic following repair in human cells Nucleic Acids Res. 27:1999;4282-4290.
61. 125I in a triplex-forming oligonucleotide Radiat. Res. 156:2001;158-166.
62. Marchand C., Nguyen C.H., Ward B., Sun J.S., Bisagni E., Garestier T., Helene C. A new family of sequence-specific DNA-cleaving agents directed by triple-helical structures: benzopyridoindole-EDTA conjugates. Chemistry. 6:2000;1559-1563.
63. Karamychev V.N., Reed M.W., Neumann R.D., Panyutin I.G. Distribution of DNA strand breaks produced by iodine-123 and indium-111 in synthetic oligodeoxynucleotides. Acta Oncol. 39:2000;687-692.
64. Arimondo P.B., Moreau P., Boutorine A., Bailly C., Prudhomme M., Sun J.S., Garestier T., Helene C. Recognition and cleavage of DNA by rebeccamycin- or benzopyridoquinoxaline conjugated of triple helix-forming oligonucleotides. Bioorg. Med. Chem. 8:2000;777-784.
65. Nunez M.E., Noyes K.T., Gianolio D.A., McLaughlin L.W., Barton J.K. Long-range guanine oxidation in DNA restriction fragments by a triplex-directed naphthalene diimide intercalator. Biochemistry. 39:2000;6190-6199.
66. Arimondo P.B., Bailly C., Boutorine A.S., Moreau P., Prudhomme M., Sun J.S., Garestier T., Helene C. Triple helix-forming oligonucleotides conjugated to indolocarbazole poisons direct topoisomerase I-mediated DNA cleavage to a specific site. Bioconjug. Chem. 12:2001;501-509.
67. Oh D.H., King B.A., Boxer S.G., Hanawalt P.C. Spatially localized generation of nucleotide sequence-specific DNA damage. Proc. Natl. Acad. Sci. U.S.A. 98:2001;11271-11276.
68. Arimondo P.B., Boutorine A., Baldeyrou B., Bailly C., Kuwahara M., Hecht S.M., Sun J.S., Garestier T., Helene C. Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I. J. Biol. Chem. 277:2002;3132-3140.
69. Ritchie S., Boyd F.M., Wong J., Bonham K. Transcription of the human c-src promoter is dependent on Sp1, a novel pyrimidine binding factor SPy, and can be inhibited by triplex-forming oligonucleotides. J. Biol. Chem. 275:2000;847-854.
70. H. Simon, I. Fortsch, G. Burckhardt, A. Gabrielyan, E. Birch-Hirschfeld, A. Stelzner, I. Prevot-Halter, C. Leumann, C. Zimmer, Triple helix formation inhibits DNA gyrase activity, Antisense Nucleic Acid Drug Dev. (1999) 527-531.
71. Bailey C., Weeks D.L. Understanding oligonucleotide-mediated inhibition of gene expression in Xenopus laevis oocytes. Nucleic Acids Res. 28:2000;1154-1161.
72. Faria M., Wood C.D., Perrouault L., Nelson J.S., Winter A., White M.R., Helene C., Giovannangeli C. Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3862-3867.
73. Cogoi S., Suraci C., Del Terra E., Diviacco S., van der Marel G., van Boom J., Quadrifoglio F., Xodo L. Down-regulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells. Antisense Nucleic Acid Drug Dev. 10:2000;283-295.
74. Cheng B., Fournier R.L., Relue P.A. The inhibition of Escherichia coli lac operon gene expression by antigene oligonucleotides-mathematical modeling. Biotechnol. Bioeng. 70:2000;467-472.
75. Intody Z., Perkins B.D., Wilson J.H., Wensel T.G. Blocking transcription of the human rhodopsin gene by triplex-mediated DNA photocrosslinking. Nucleic Acids Res. 28:2000;4283-4290.
76. Shen C., Buck A., Mehrke G., Polat B., Gross H., Bachem M., Reske S. Triplex-forming oligonucleotide targeted to 3′-UTR down-regulates the expression of the bcl-2 proto-oncogene in HeLa cells. Nucleic Acids Res. 29:2001;622-628.
77. Liu J., Xu R., Jin Y., Wang D. Triplex targeting of human PDGF-B (c-sis, proto-oncogene) promoter specifically inhibits factors binding and PDGF-B transcription. Nucleic Acids Res. 29:2001;783-791.
78. Cogoi S., Rapozzi V., Quadrifoglio F., Xodo L. Antigene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages. Biochemistry. 40:2001;1135-1143.
79. Faria M., Wood C.D., White M.R., Helene C., Giovannangeli C. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells. J Mol. Biol. 306:2001;15-24.
80. 125I -labeled triplex-forming oligonucleotides Antisense Nucleic Acid Drug Dev. 10:2000;443-452.
81. Hiratou T., Tsukahara S., Miyano-Kurosaki N., Takai K., Saito T., Yamamoto N., Takaku H. Anti-HIV-1 activity by a triple helix-forming oligonucleotides targeted to polypurine tract on viral RNA. Nucleosides Nucleotides Nucleic Acids. 19:2000;1721-1734.
82. Meunier L., Monsigny M., Roche A.C. Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation. Antisense Nucleic Acid Drug Dev. 11:2001;117-123.
83. Biet E., Maurisse R., Dutreix M., Sun Js. Stimulation of RecA-mediated D-loop formation by oligonucleotide-directed triple helix formation: guided homologous recombination (GOREC). Biochemistry. 40:2001;1779-1786.
84. Stutz A.M., Hoeck J., Natt F., Cuenoud B., Woisetschlager M. Inhibition of interleukin-4- and CD40-induced IgE germline gene promoter activity by 2′-aminoethoxy-modified triplex-forming oligonucleotides. J. Biol. Chem. 276:2001;11759-11765.
85. Cheng B., Fournier R.L., Relue P.A., Schisler J. An experimental and theoretical study of the inhibition of Escherichia coli lac operon gene expression by antigene oligonucleotides. Biotechnol. Bioeng. 74:2001;220-229.
86. Hai M., Bidichandani S.I., Hogan M.E., Patel P.I. Competitive binding of triplex-forming oligonucleotides in the two alternate promoters of the PMP22 gene. Antisense Nucleic Acid Drug Dev. 11:2001;233-246.
87. Rapozzi V., Cogoi S., Spessotto P., Risso A., Bonora G.M., Quadrifoglio F., Xodo L.E. Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene. Biochemistry. 41:2002;502-510.
88. Kuznetsova S., Ait-Si-Ali S., Nagibneva I., Troalen F., Le Villain J.P., Harel-Bellan A., Svinarchuk F. Gene activation by triplex-forming oligonucleotide coupled to the activating domain of protein VP16. Nucleic Acids Res. 27:1999;3995-4000.
89. Bates P.J., Kahlon J.B., Thomas S.D., Trent J.O., Miller D.M. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J. Biol. Chem. 274:1999;26369-26377.
90. Xu X., Hamhouyia F., Thomas S.D., Burke T.J., Girvan A.C., McGregor W.G., Trent J.O., Miller D.M., Bates P.J. Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J. Biol. Chem. 276:2001;43221-43230.
91. Moine H., Mandel J.L. Biomedicine: Do G-quartets orchestrate fragile X pathology? Science. 294:2001;2487-2488.
92. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., Darnell R.B., Warren S.T. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 107:2001;477-487.
93. Sun H., Yabuki A., Maizels N. A human nuclease specific for G4 DNA. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12444-12449.
94. Lin Y.C., Shih J.W., Hsu C.L., Lin J.J. Binding and partial denaturing of G-quartet DNA by Cdc13p of Saccharomyces cerevisiae. J. Biol. Chem. 276:2001;47671-47674.
95. Joseph J., Kandala J.C., Veerapanane D., Weber K.T., Guntaka R.V. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat α1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts. Nucleic Acids Res. 25:1997;2182-2188.
96. Nakanishi M., Weber K.T., Guntaka R.V. Triple helix formation with the promoter of human α1(I) procollagen gene by an antiparallel triplex-forming oligodeoxyribonucleotide. Nucleic Acids Res. 26:1998;5218-5222.
97. Opalinska J.B., Gewirtz A.M. Nucleic acid therapeutics: basic principles and recent applications. Nat. Rev. Drug Discov. 1:2002;503-514.